Krispy Kreme, Inc.
For the period ended Sep 28, 2025. Filed Nov 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 28, 2025 · Filed Nov 6, 2025
DNUT$3.85-4.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
Condensed Consolidated Statements of Cash Flows (Unaudited)
(in thousands)
| Three Quarters Ended | ||
|---|---|---|
| September 28, 2025 (39 weeks) | September 29, 2024 (39 weeks) | |
| CASH FLOWS (USED FOR)/PROVIDED BY OPERATING ACTIVITIES: | ||
| Net (loss)/income | $(494,654) | $25,978 |
| Adjustments to reconcile net (loss)/income to net cash (used for)/provided by operating activities: | ||
| Depreciation and amortization expense | 103,129 | 99,562 |
| Deferred and other income taxes | (37,396) | (22) |
| Goodwill impairment | 355,958 | — |
| Other asset impairments and lease termination charges | 55,941 | 368 |
| Loss on disposal of property and equipment | 1,466 | 470 |
| Loss/(gain) on divestiture of Insomnia Cookies | 11,501 | (87,128) |
| Gain on refranchising | (1,063) | — |
| Gain on remeasurement of equity method investment | — | (5,579) |
| Gain on sale-leaseback | (6,749) | — |
| Share-based compensation | 8,011 | 24,603 |
| Change in accounts and notes receivable allowances | 1,080 | 433 |
| Inventory write-off | 6,418 | 1,731 |
| Amortization related to settlement of interest rate swap derivatives | — | (5,910) |
| Other | 317 | 263 |
| Change in operating assets and liabilities, excluding business acquisitions and divestitures, and foreign currency translation adjustments | (15,054) | (35,982) |
| Net cash (used for)/provided by operating activities | (11,095) | 18,787 |
| CASH FLOWS PROVIDED BY INVESTING ACTIVITIES: | ||
| Purchase of property and equipment | (80,844) | (86,877) |
| Proceeds from sale-leaseback | 10,882 | — |
| Acquisition of shops and franchise rights from franchisees, net of cash acquired | — | (26,612) |
| Purchase of equity method investment | (2,998) | (3,506) |
| Net proceeds from divestiture of Insomnia Cookies | 75,000 | 117,646 |
| Principal payment received from loan to Insomnia Cookies | — | 45,000 |
| Principal payments received from loans to franchisees | 1,202 | — |
| Disbursement for loan receivable | — | (1,086) |
| Other investing activities | 177 | 180 |
| Net cash provided by investing activities | 3,419 | 44,745 |
| CASH FLOWS PROVIDED BY/(USED FOR) FINANCING ACTIVITIES: | ||
| Proceeds from the issuance of debt | 661,026 | 490,000 |
| Repayment of long-term debt and lease obligations | (606,581) | (545,692) |
| Payment of financing costs | (825) | — |
| Proceeds from structured payables | 242,350 | 298,551 |
| Payments on structured payables | (270,418) | (264,346) |
| Capital contribution by shareholders, net of loans issued | — | 919 |
| Proceeds from sale of noncontrolling interest in subsidiary | — | 364 |
| Distribution to shareholders | (11,934) | (17,743) |
| Payments for repurchase and retirement of common stock | (1,184) | (4,366) |
| Distribution to noncontrolling interest | (36) | (35,035) |
| Net cash provided by/(used for) financing activities | 12,398 | (77,348) |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | (2,885) | 1,086 |
| Net increase/(decrease) in cash, cash equivalents and restricted cash | 1,837 | (12,730) |
| Cash, cash equivalents and restricted cash at beginning of period | 29,315 | 38,614 |
| Cash, cash equivalents and restricted cash at end of period | $31,152 | $25,884 |
| Supplemental schedule of non-cash investing and financing activities: | ||
| (Decrease)/increase in accrual for property and equipment | $(12,363) | $12,362 |
| Accrual for distribution to shareholders | — | (5,943) |
| Reconciliation of cash, cash equivalents and restricted cash at end of period: | ||
| Cash and cash equivalents | $30,707 | $25,410 |
| Restricted cash | 445 | 474 |
| Total cash, cash equivalents and restricted cash | $31,152 | $25,884 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.